Top 5 Zacks #1 Ranked Healthcare Mutual Funds - Best of Funds
02 Gennaio 2013 - 6:16PM
Zacks
The healthcare sector is one of the most desirable avenues for
parking investments when markets are headed south. The demand for
such services usually remains unchanged even during an economic
downturn and investments in the sector provide sufficient
protection to the capital invested. Several pharmaceutical
companies also provide regular dividends, which can help mitigate
losses from falling share prices. Healthcare mutual funds provide
the perfect avenue for investors looking to invest in this
sector.
Below we will share with you 5 top rated health mutual funds.
Each has earned a Zacks #1 Rank (Strong Buy) as we expect these
mutual funds to outperform their peers in the future. To view the
Zacks Rank and past performance of all health funds, investors can
click here to see the complete list of funds.
Fidelity Select Biotechnology (FBIOX) invests the
majority of its assets in common stocks of such companies which are
primarily involved in activities involving new scientific and
technological developments in biotechnology. It focuses on both
domestic and foreign securities. The healthcare mutual fund has a
one year annualized return of 42.05%.
Rajiv Kaul is the fund manager and has managed this healthcare
mutual fund since 2005.
Rydex Biotechnology (RYOIX) seeks capital growth. The
fund invests heavily in equity securities and derivatives issued by
domestic biotechnology companies. It focuses on small and mid-cap
biotechnology companies. It is non-diversified and seeks capital
growth. The healthcare mutual fund has a one year annualized return
of 41.92%. < p> As of November 2012, this healthcare mutual
fund held 47 issues, with 9.61% of its total assets invested in
Amgen Inc.
Delaware Healthcare A (DLHAX) invests the majority of its
assets in the healthcare sector. It purchases equity of both
domestic and foreign companies regardless of their size. It may
also invest in emerging market stocks. The healthcare mutual fund
has a one year annualized return of 16.04%.
The healthcare mutual fund has a minimum initial investment of $
1,000 and an expense ratio of 1.55% compared to a category average
of 1.53%.
VALIC Company I Health Sciences (VCHSX) seeks long term
capital growth. The fund invests the majority of its assets in
common stocks of healthcare products, medicine or life sciences
related companies. It focuses mainly on investing in large and
mid-cap companies. Not more than 35% of its assets may be invested
foreign securities. The healthcare mutual fund has a one year
annualized return of 32.29%.
Kris H. Jenner is the fund manager and has managed this
healthcare mutual fund since 2000.
T. Rowe Price Health Sciences (PRHSX) invests the
majority of its assets in common stocks of companies whose primary
operations are related to health sciences. The fund focuses on
investing in large and mid-cap firms. It may also invest in foreign
securities. The healthcare mutual fund has a one year annualized
return of 32.37%.
The healthcare mutual fund has a minimum initial investment of $
2,500 and an expense ratio of 0.82% compared to a category average
of 1.53%.
To view the Zacks Rank and past performance of all health mutual
funds, investors can click here to see the complete list of
funds.
About Zacks Mutual Fund Rank
By applying the Zacks Rank to mutual funds, investors can find
funds that not only outpaced the market in the past but are also
expected to outperform going forward. Learn more about the Zacks
Mutual Fund Rank.
View All Zacks #1 Ranked Mutual Funds
(DLHAX): ETF Research Reports
(FBIOX): ETF Research Reports
(PRHSX): ETF Research Reports
(RYOIX): ETF Research Reports
(VCHSX): ETF Research Reports
To read this article on Zacks.com click here.
Zacks Investment Research